Stockholders of Neogen Corporation Facing Major Losses Should Reach Out to Robbins LLP for Class Action Details

Neogen Corporation Class Action Lawsuit Overview

In a significant development, Robbins LLP has brought attention to stockholders of Neogen Corporation who have suffered considerable financial losses due to misleading information about the company's integration with 3M Company. This class action lawsuit is specifically for investors who purchased shares of Neogen (NASDAQ: NEOG) between January 6, 2023, and June 3, 2025.

Neogen focuses on food safety, manufacturing products related to both food and animal safety. Recently, the company faced serious allegations regarding its handling of the acquisition process with 3M, which has raised concerns among investors. According to the lawsuit, Neogen's executives issued a series of deceptive statements that misinformed investors about the successful integration with 3M. This resulted in a false sense of security, concealing the problematic aspects of the merging which adversely impacted the company's fiscal health.

Allegations Against Neogen

The complaint outlines that Neogen misrepresented critical details about its integration status. On January 10, 2025, it was revealed that Neogen's financial performance was in decline, posting a significant GAAP net income loss attributed to a non-cash goodwill impairment of $461 million from the 3M acquisition. This disclosure resulted in a 5% drop in the stock price, which closed at $12.36. Furthermore, the company revised its revenue and EBITDA guidance downwards for the fiscal year 2025, indicating further trouble ahead.

Continuing down this troubled path, Neogen announced on April 9, 2025, that its quarterly revenue dropped by 3.4% to $221 million due to ongoing integration struggles, leading to another adjustment in its financial outlook. This announcement caused a dramatic 28% stock price plunge. Investors were alarmed when they learned that Neogen's CEO was stepping down, underscoring the extent of the issues within the company.

The most recent updates on June 4, 2025, indicated a further decline—Neogen projected an EBITDA margin drop to the high teens from a previous 22%. This news catalyzed another catastrophic hit on the stock, with a 17% decrease in value, resulting in shares closing at $4.96. From a peak of $23.84 in 2023, Neogen's stock has plummeted 79%, erasing over $4 billion from its market capitalization.

Participation in the Class Action

Stockholders who have been impacted by these events may be entitled to join the class action lawsuit against Neogen Corporation. Robbins LLP encourages affected investors looking to serve as lead plaintiffs to come forward. A lead plaintiff plays a crucial role in representing the group in court, but individuals can still benefit from the lawsuit without being actively involved.

All representation from Robbins LLP operates on a contingency basis, meaning that shareholders will not incur any fees unless there is a successful recovery.

Robbins LLP has a respected reputation in shareholder rights litigation since 2002, advocating for investors in recovering losses, enhancing corporate governance, and holding companies accountable for wrongful conduct.

Closing Thoughts

For those interested in staying informed, signing up for Stock Watch can provide automatic notifications if a resolution occurs in the Neogen Corporation class action. The legal landscape for investors can often be complex, but support systems like Robbins LLP aim to make the journey smoother and ultimately more fruitful for those affected.

For more assistance, investors can contact Robbins LLP directly via email or phone at (800) 350-6003.

Attorney Advertising. Past results do not guarantee a similar outcome.